Evidence map›Paper›PMID 28179282›Full record

ReviewBlood2017

The GATA factor revolution in hematology.

Koichi R Katsumura, Emery H Bresnick, GATA Factor Mechanisms Group

Open access · bronzeAbstract readReview
In one paragraph

Review in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 1 synthesis or guideline pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nutrigenomic profiling identifies ZIP10 (Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. mInternational journal of molecular sciences · 2025
    Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Koichi R KatsumuraDepartment of Cell and Regenerative Biology, UW-Madison Blood Research Program, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Emery H BresnickDepartment of Cell and Regenerative Biology, UW-Madison Blood Research Program, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI.
GATA Factor Mechanisms Group
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
Hematopoietic Regulation via GATA SwitchesR01DK068634 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Emery H. Bresnick · 2006 to 2026
$7.5M
Transcriptional Control of Hemoglobin Synthesis and Erythrocyte DevelopmentR01DK050107 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Emery H. Bresnick · 1996 to 2026
$6.1M
Transcriptional Control of Hemoglobin SynthesisR37DK050107 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI BRESNICK, EMERY H · 2011 to 2020
$3.5M
Novel Determinants of Terminal Erythroid MaturationR01HL116365 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BRESNICK, EMERY H, GHAFFARI, SAGHI · 2012 to 2015
$1.6M
Mechanisms of a GATA Factor-Dependent Hematopoietic Signaling PathwayK01DK113117 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI HEWITT, KYLE J · 2017 to 2018
$199k
Hematopoietic Regulation Via GATA SwitchesR56DK068634 · NIDDK · UNIVERSITY OF WISCONSIN MADISON · PI BRESNICK, EMERY H. · 2005 to 2005
$109k
NCI NIH HHS P30 CA014520NHLBI NIH HHS R01 HL116365NHLBI NIH HHS T32 HL007899NIDDK NIH HHS K01 DK113117NIDDK NIH HHS R01 DK050107NIDDK NIH HHS R01 DK068634NIDDK NIH HHS R37 DK050107NIDDK NIH HHS R56 DK068634
6 · The paper itself

Abstract

The discovery of the GATA binding protein (GATA factor) transcription factor family revolutionized hematology. Studies of GATA proteins have yielded vital contributions to our understanding of how hematopoietic stem and progenitor cells develop from precursors, how progenitors generate red blood cells, how hemoglobin synthesis is regulated, and the molecular underpinnings of nonmalignant and malignant hematologic disorders. This thrilling journey began with mechanistic studies on a β-globin enhancer- and promoter-binding factor, GATA-1, the founding member of the GATA family. This work ushered in the cloning of related proteins, GATA-2-6, with distinct and/or overlapping expression patterns. Herein, we discuss how the hematopoietic GATA factors (GATA-1-3) function via a battery of mechanistic permutations, which can be GATA factor subtype, cell type, and locus specific. Understanding this intriguing protein family requires consideration of how the mechanistic permutations are amalgamated into circuits to orchestrate processes of interest to the hematologist and more broadly.

Indexed as

beta-GlobinsEnhancer Elements, GeneticGATA Transcription FactorsGene Expression Regulation, NeoplasticHematologic NeoplasmsAnimalsHematopoietic Stem CellsHumansbeta-GlobinsGATA Transcription Factors

Identifiers

PMID28179282
PMCPMC5391619
OpenAlexW2586539764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.